Total Funding
38
70
Total FundingDebt Financing raised
Growth Score 38 in past quarter
-1 pts
Heat Score 70 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
116093
Phronesis Artificial Intelligence produces pharmaceutical software for autonomous drug design.
- Will Spagnoli: Founder & CTO
- Rick Fine: Founder & CEO
About the Company
Phronesis Artificial Intelligence produces pharmaceutical software for autonomous drug design. Its platform, LIME, is transforming the drug discovery process. The company combines the latest tools in AI technology with plethoras of small molecular data to discover new candidates and medicines for targeted diseases.